AI주식인사이트AI Stock Insight
C

뷰노

338220KOSDAQ소프트웨어 개발 및 공급업

43.6 / 100

Reference Date: 2026-06-10

Financial Score15.0 / 40
News Sentiment15.6 / 25
Momentum3.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Plunged 41.0% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

VUNO is a pioneer in medical IT, leveraging deep learning to provide innovative solutions such as cardiac arrest prediction, fundus image analysis, and chest X-ray diagnostics. Its key product, VUNO Med-DeepCARS, received FDA Breakthrough Device Designation in 2023 and is actively expanding into the U.S. market. The company is transitioning to a SaaS-based subscription model, with the prognosis and prediction solutions driving the majority of its revenue.

Number of Employees

165people

Average Salary

80.5M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 13.624.0Point
PBR
3.02Industry Average 1.020.0Point

3.0x industry avg (risky)

ROE
-17.30Industry Average 1.100.0Point

Well below industry avg

Debt Ratio
5.13Industry Average 7.935.0Point

Lower than industry avg (good)

Trend 2023~20256.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲64.8% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲40.5% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -74.0% (improving, 3yr)

Detailed News Sentiment

4 totalPositive 1Neutral 2Negative 1Average Sentiment Score 62.5

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 7,780Won52-week high 27,60052-week low 7,780
1-month return0.0Point

1m -40.97% (strong drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0
  • Neutral분기보고서 (2026.03)2026-05-15